4.7 Article

A Specific Mutational Signature Associated with DNA 8-Oxoguanine Persistence in MUTYH-defective Colorectal Cancer

期刊

EBIOMEDICINE
卷 20, 期 -, 页码 39-49

出版社

ELSEVIER SCIENCE BV
DOI: 10.1016/j.ebiom.2017.04.022

关键词

MUTYH-associated polyposis; Colorectal cancer; 8-Oxoguanine; Base excision repair; Exome sequencing; Mutational signature

资金

  1. Associazione Italiana Ricerca sul Cancro [11755, 17583, 9979]
  2. Italian Ministry of Health [RF-2008]
  3. J. Robert Oppenheimer Fellowship at Los Alamos National Laboratory
  4. U.S. Department of Energy National Nuclear Security Administration [DE-AC5206NA25396]
  5. National Nuclear Security Administration of the United States Department of Energy

向作者/读者索取更多资源

8-Oxoguanine, a common mutagenic DNA lesion, generates G:C>T:A transversions via mispairing with adenine during DNA replication. When operating normally, the MUTYH DNA glycosylase prevents 8-oxoguanine-related mutagenesis by excising the incorporated adenine. Biallelic MUTYH mutations impair this enzymatic function and are associated with colorectal cancer (CRC) in MUTYH-Associated Polyposis (MAP) syndrome. Here, we perform whole-exome sequencing that reveals a modest mutator phenotype in MAP CRCs compared to sporadic CRC stem cell lines or bulk tumours. The excess G:C>T:A transversion mutations in MAP CRCs exhibits a novel mutational signature, termed Signature 36, with a strong sequence dependence. The MUTYH mutational signature reflecting persistent 8-oxoG:A mismatches occurs frequently in the APC, KRAS, PIK3CA, FAT4, TP53, FAT1, AMER1, KDM6A, SMAD4 and SMAD2 genes that are associated with CRC. The occurrence of Signature 36 in other types of human cancer indicates that DNA 8-oxoguanine-relatedmutations might contribute to the development of cancer in other organs. (C) 2017 The Authors. Published by Elsevier B.V.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据